Canadian Sec - Delayed Quote CAD

Treatment.com AI Inc. (TRUE.CN)

Compare
0.6800
+0.0900
+(15.25%)
At close: January 10 at 3:59:32 PM EST

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.
NameTitlePayExercisedYear Born
Dr. Essam Hamza M.D. CEO & Director -- -- 1971
Mr. David Worner Chief Financial Officer -- -- 1979
Mr. Richard Atkins Chief Operating Officer -- -- --
Ms. Samantha Rayner Vice President of Marketing -- -- --
Dr. Robert Scott M.D. Chief Innovation Officer -- -- --

Treatment.com AI Inc.

800 – 885 West Georgia Street
Vancouver, BC V6C 3H1
Canada
https://www.treatment.com
Sector: 
Healthcare

Description

Treatment.Com International Inc. provides personalized health care information services in Canada. The company develops a mobile application for symptom assessment of users to address their health concerns, problems, and ongoing wellness management. It also offers a digital health app, an assessment tool which provides insights about health. In addition, the company provides medical education, medical clinic, and clinical advisor solutions; and offers healthcare information resource. Treatment.Com International Inc. was incorporated in 2018 and is headquartered in Vancouver, Canada.

Corporate Governance

Treatment.com AI Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers